-
1Academic Journal
-
2Academic Journal
-
3Academic Journal
Authors: P. Yu. Grishko, A. V. Mishchenko, O. V. Ivko, D. V. Samsonov, A. M. Karachun, П. Ю. Гришко, А. В. Мищенко, О. В. Ивко, Д. В. Самсонов, А. М. Карачун
Source: Surgery and Oncology; Том 10, № 1 (2020); 20-27 ; Хирургия и онкология; Том 10, № 1 (2020); 20-27 ; 2949-5857
Subject Terms: выживаемость, diagnostics, disease extent assessment, neoadjuvant chemotherapy, magnetic resonance imaging, survival, диагностика, оценка распространенности, неоадъювантное лечение, магнитно-резонансная томография
File Description: application/pdf
Relation: https://www.onco-surgery.info/jour/article/view/462/331; Tudyka V., Blomqvist L., Beets-Tan R.G.H. et al. EURECCA consensus conference highlights about colon & rectal cancer multidisciplinary management: The radiology experts review. Ejso 2014;40(4):469–75. DOI:10.1016/j.ejso.2013.10.029.; Sauer R., Becker H., Hohenberger W. et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. New Engl J Med 2004;351(17):1731–40. DOI:10.1056/NEJMoa040694.; Kapiteijn E., Marijnen C.A.M., Nagtegaal I.D. et al. Dutch Colorectal Canc G. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. New Engl J Med 2001;345(9):638–46. DOI:10.1056/NEJMoa010580.; Patel U.B., Taylor F., Blomqvist L. et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol 2011;29(28):3753–60. DOI:10.1200/JCO.2011.34.9068.; Lee E.S., Kim M.J., Park S.C. et al. Magnetic resonance imaging-detected extramural venous invasion in rectal cancer before and after preoperative chemoradiotherapy: diagnostic performance and prognostic significance. Eur Rad 2018;28(2):496–505. DOI:10.1007/s00330-017-4978-6.; Patel U.B., Brown G., Machado I. et al. MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial. Ann Oncol 2017;28(2):344–53. DOI:10.1093/annonc/mdw616.; Habr-Gama A., Gama-Rodrigues J., Juliao G.P.S. et al. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. Int J Rad Oncol Biol Phys 2014;88(4):822–8. DOI:10.1016/j.ijrobp.2013.12.012; Patel U.B., Brown G., Rutten H. et al. Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Ann Surg Oncol 2012;19(9):2842–52.; Xiao H., Tan Y.T., Li W.Y. et al. Tumor volume reduction rate is superior to RECIST for predicting the pathological response of rectal cancer treated with neoadjuvant chemoradiation: Results from a prospective study. Oncol Lett 2015;9(6):2680–6. DOI:10.1245/s10434-012-2309-3.; Yeo S.-G., Kim D.Y., Park J.W. et al. Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer. Int J Rad Oncol Biol Phys 2012;82(2):193–9. DOI:10.1016/j.ijrobp.2011.03.022.; Han Y.B., Oh S.N., Choi M.H. et al. Clinical impact of tumor volume reduction in rectal cancer following preoperative chemoradiation. Diagn Interv Imaging 2016;97(9):843–50.; Nougaret S., Rouanet P., Molinari N. et al. MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy. Radiology 2012;263(2):409–18. DOI:10.1148/radiol.12111263.; Yu S.K.T., Tait D., Chau I., Brown G. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy – implications for induction chemotherapy? Int J Rad Oncol Biol Phys 2013;87(3):505–11. DOI:10.1016/j.ijrobp.2013.06.2052.; Kuo L.-J., Liu M.-C., Jian J.J.-M. et al. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol 2007;14(10):2766–72. DOI:10.1245/s10434-007-9471-z.; Siddiqui M.R.S., Bhoday J., Battersby N.J. et al. Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales. World J Gastroenterol 2016;22(37):8414–34. DOI:10.3748/wjg.v22.i37.8414.; Sclafani F., Brown G., Cunningham D. et al. PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer. Ann Oncol 2016;27(8):1557–65. DOI:10.1093/annonc/mdw215.; Rullier E., Rouanet P., Tuech J.J. et al. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial. Lancet 2017;390(10093):469–79. DOI:10.1016/S0140-6736(17)31056-5.; Benson A.B., Venook A.P., Al-Hawary M.M. et al. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. JNCCN 2018;16(7):874–901. DOI:10.6004/jnccn.2018.0061.
-
4Academic Journal
Authors: A. S. Petrova, O. A. Smirnova, A. V. Mishchenko, I. V. Berlev, E. A. Ulrich, H. B. Mkrtchyan, A. B. Kosichkina, A. O. Nyuganen, А. С. Петрова, О. А. Смирнова, А. В. Мищенко, И. В. Берлев, Е. А. Ульрих, Г. Б. Мкртчян, А. Б. Косичкина, А. О. Нюганен
Source: Medical Visualization; № 3 (2019); 82-106 ; Медицинская визуализация; № 3 (2019); 82-106 ; 2408-9516 ; 1607-0763
Subject Terms: хирургическое лечение, diagnostics, disease extent assessment, neoadjuvant treatment, magnetic resonance imaging, prognostic factors, surgical treatment, диагностика, оценка распространенности, неоадъювантное лечение, магнитно-резонансная томография, прогностические факторы
File Description: application/pdf
Relation: https://medvis.vidar.ru/jour/article/view/797/565; GLOBOCAN 2018. Estimated cancer incidence, mortality and prevalence worldwide in 2012. [cited12 Sept 2018]. URL: http://gco.iarc.fr; Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2017 году М.: МНИОИ им. П.А. Герцена – филиал ФГБУ “НМИЦ радиологии” Минздрава России, 2018. 236 с.; In situ cervical carcinoma incidence statistics URL: https://www.cancerresearchuk.org/health-professional/cancerstatistics/statistics-by-cancer-type/cervical-cancer/incidence-in-situ?_ga=2.135120753.116604086.1551041700-535305463.1543059799; Barchuk A., Bespalov A., Huhtalac H., Chimedd T., Laricheva I., Belyaev A., Brayd F., Anttila A., Auvinen A. Breast and cervical cancer incidence and mortality trends in Russia 1980–2013. Cancer Epidemiol. 2018; 55: 73–80. https://doi.org/10.1016/j.canep.2018.05.008.; International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int. J. Cancer. 2007; 120 (4): 885.; Downey K., Riches S.F., Morgan A.V., Giles S., Attygalle A.D., Ind T.E.J., Barton D., Shepherd J.H , Desouza N.M. Relationship between imaging biomarkers of stage I cervical cancer and poor prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images. Am. J. Roentgenol. 2013; 200 (2): 314–320. https://doi.org/10.2214/AJR.12.9545.; Follen M., Levenback C.F., Iyer R.B., Grigsby P.W., Boss E.A., Delpassand E.S., Fornage B.D., Fishman E.K. Imaging in cervical cancer. Cancer. 2003; 98 (9): 2028–2038.; Bourgioti C., Chatoupis K., Moulopoulos L.A. Current imaging strategies for the evaluation of uterine cervical cancer. Wld J. Radiol. 2016; 8 (4): 342–354. https://doi.org/10.4329/wjr.v8.i4.342.; Рубцова Н.А., Новикова Е.Г., Синицын В.Е. Возможности МРТ в предоперационной оценке местной распространенности рака шейки матки. Радиология-практика. 2012; 3: 51–64.; Balleyguier C., Sala E., Da Cunha T., Bergman A., Brkljacic B., Danza F., Forstner R., Hamm B., Kubik-Huch R., Lopez C., Manfredi R., McHugo J., Oleaga L., Togashi K., Kinkel K. Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur. Radiol. 2011; 21: 1102–1110. https://doi.org/10.1007/s00330-010-1998-x.; Dappa E., Elger T., Hasenburg A., Düber C., Battista M.J., Hötker A.M. The value of advanced MRI techniques in the assessment of cervical cancer: a review. Insights Imaging. 2017; 8: 471–481. https://doi.org/10.1007/s13244-017-0567-0.; Bleker S.M., Bipat S., Spijkerboer A.M., van der Velden J., Stoker J., Kenter G.G. The negative predictive value of clinical examination with or without anesthesia versus magnetic resonance imaging for parametrial infiltration in cervical cancer stages IB1 to IIA. Int. J. Gynecol. Cancer. 2013; 23:193–198. https://doi.org/10.1097/IGC.0b013e31827a4ad8.; Dhoot N.M., Kumar V., Shinagare A., Kataki A.C., Barmon D., Bhuyan U. Evaluation of carcinoma cervix using magnetic resonance imaging: correlation with clinical FIGO staging and impact on management. J. Med. Imaging Radiat. Oncol. 2012; 56: 58–65. https://doi.org/10.1111/j.1754-9485.2011.02333.x.; Кудреватых Е.В. Магнитно-резонансная томография в диагностике и оценке результатов комплексного лечения рака шейки матки: Автореф. дис. . канд. мед. наук. М., 2011. 24 с.; Bhosale P., Peungjesada S., Devine C., Balachandran A., Iyer R. Role of magnetic resonance imaging as an adjunct to clinical staging in cervical carcinoma. J. Comput. Assist. Tomogr. 2010; 34 (6): 855–864. https://doi.org/10.1097/RCT.0b013e3181ed3090.; Sala E., Wakely S., Senior E., Lomas D. MRI of malignant neoplasms of the uterine corpus and cervix. Am. J. Roentgenol. 2007; 188: 1577–1587. https://doi.org/10.2214/AJR.06.1196.; Nicolate V., Carignan L., Bourdon F., Prosmanne O. MR imaging of cervical carcinoma: A practical staging approach. RadioGraphics. 2000; 20: 1539–1549. https://doi.org/10.1148/radiographics.20.6.g00nv111539.; Sala E., Rockall A.G., Freeman S.J., Mitchell D.G., Reinhold C. The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology. 2013; 266: 717–740. https://doi.org/10.1148/radiol.12120315.; Sakuragi N., Satoh C., Takeda N., Hareyama H., Takeda M., Yamamoto R., Fujimoto T., Oikawa M., Fujino T., Fujimoto S. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer. 1999; 85: 1547–1554.; Eisenhauera E.A., Therasseb P., Bogaertsc J., Schwartzd L.H., Sargente D., Fordf R., Danceyg J., Arbuckh S., Gwytheri S., Mooneyg M., Rubinsteing L., Shankarg L., Doddg L.,Kaplanj R., Lacombec D., Verweij J. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur. J. Cancer. 2009; 45: 228–247. https://doi.org/10.1016/j.ejca.2008.10.026.; Hong K.S., Ju W., Choi H.J., Kim J.K., Kim M.H., Cho K.S. Differential diagnostic performance of magnetic resonance imaging in the detection of lymph node metastases according to the tumor size in early-stage cervical cancer patients. Int. J. Gynecol. Cancer. 2010; 20: 841–846. https://doi.org/10.1111/IGC.0b013e3181db5140.; Shen G., Zhou H., Jia Z., Deng H. Diagnostic performance of diffusion-weighted MRI for detection of pelvic metastatic lymph nodes in patients with cervical cancer: a systematic review and meta-analysis. Br. J. Radiol. 2015; 88 (1052): 20150063. https://doi.org/10.1259/bjr.20150063.; Drieskens O., Stroobants S., Gysen M., Vandenbosch G., Mortelmans L., Vergote I. Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer. Gynecol. Obstet. Invest. 2003; 55: 130–134. https://doi.org/10.1159/000071525.; Singh N., Arif S. Histopathologic parameters of prognosis in cervical cancer – a review. Int. J. Gynecol. Cancer. 2004; 14: 741–750. https://doi.org/10.1111/j.1048-891X.2004.014504.x.; Reagan J.W., Fu Y.S. Histologic types and prognosis of cancers of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 1979; 5: 1015–1020.; Crissman J.D., Budhraja M., Aron B.S. et al. Histopathologic prognostic factors in stage II and III squamous cell carcinoma of the uterine cervix. Int. J. Gynecol. Pathol. 1987; 6: 97–103.; Cohen J.G., Kapp D.S., Shin J.Y. et al. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am. J. Obstet Gynecol. 2010; 203 (347): 341–346. https://doi.org/10.1016/j.ajog.2010.04.019.; Mangler M., Lanowska M., Kohler C., Vercellino F., Schneider A., Speiser D. Pattern of cancer recurrence in 320 patients after radical vaginal trachelectomy. Int. J. Gynecol Cancer. 2014; 24: 130–134. https://doi.org/10.1097/IGC.0000000000000012.; Park J.Y., Lee J.W., Park B.K., Lee Y.Y., Choi C.H., Kim T.J., Bae D.S., Kim B.G., Park J.J., Park S.Y., Kim C.K. Postoperative outcomes of MR-invisible stage IB1 cervical cancer. Am. J. Obstet. Gynecol. 2014; 211: 168. 1–7. https://doi.org/10.1016/j.ajog.2014.02.032.; Kamimori T., Sakamoto K., Fujiwara K., Umayahara K., Sugiyama Y., Utsugi K., Takeshima N., Tanaka H., Gomi N., Takizawa K. Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging. Int. J. Gynecol. Cancer. 2011; 21: 349–354.; Bourgioti C., Chatoupis K., Rodolakis A., Antoniou A., Tzavara C., Koutoulidis V., Moulopoulos L.A. Incremental prognostic value of MRI in the staging of early cervical cancer: a prospective study and review of the literature. Clin. Imaging. 2016; 40 (1): 72–78. https://doi.org/10.1016/j.clinimag.2015.09.012.; Kim S.H., Lee H.J., Kim Y.W. Correlation between tumor size and surveillance of lymph node metastasis for IB and IIA cervical cancer by magnetic resonance images. Eur. J. Radiol. 2012; 81: 1945–1950. https://doi.org/10.1016/j.ejrad.2011.04.053.; Kang S., Kim Y.S., Choi H.J., Kim M.H., Cho K.S. Additional value of combined evaluation of tumor size with lymph node size in the detection of lymph node metastases in early-stage cervical cancer patients. J. Comput. Assist. Tomogr. 2013; 37: 572–576. https://doi.org/10.1097/RCT.0b013e31828ba718.; Perez C.A., Camel H.M., Askin F., Breaux S. Endometrial extension of carcinoma of the uterine cervix: a prognostic factor that may modify staging. Cancer. 1981; 48: 170–180.; Kim H., Kim W., Lee M., Song E., Loh J.J.K. Tumor volume and uterine body invasion assessed by mri for prediction of outcome in cervical carcinoma treated with concurrent chemotherapy and radiotherapy. Jpn J. Clin. Oncol. 2007; 37 (11): 858–866. https://doi.org/10.1093/jjco/hym109.; Finan M.A., DeCesare S., Fiorica J.V., Chambers R., Hoffman M.S., Kline R.C., Roberts W.S., Cavanagh D. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: dose the new staging system predict morbidity and survival? Gynecol. Oncol. 1996; 62: 139–147. https://doi.org/10.1006/gyno.1996.0206.; Marchiolé P., Buénerd A., Benchaib M., Nezhat K., Dargent D., Mathevet P. Clinical significance of lymphovascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study. Gynecol. Oncol. 2005; 97 (3): 727–732. https://doi.org/10.1016/j.ygyno.2005.01.004.; Memarzadeh S., Natarajan S., Dandade D.P., Ostrzega N., Saber P.A., Busuttil A., Lentz S.E., Berek J.S. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer. Obstet. Gynecol. 2003; 102 (3): 612–619.; Yang W., Qiang J.W., Tian H.P., Chen B., Wang A.J., Zhao J.G. Minimum apparent diffusion coefficient for predicting lymphovascular invasion in invasive cervical cancer. J. Magn. Reson. Imaging. 2017; 45 (6): 1771–1779. https://doi.org/10.1002/jmri.25542.; Ahlin P.A., Weiss R. Risk management and compliance in pathology and laboratory medicine. Clin. Lab. Med. 2007; 27: 859–873. https://doi.org/10.1016/j.cll.2007.07.005.; Patel S., Liyanage S.H., Sahdev A., Rockall A.G., Reznek R.H. Imaging of endometrial and cervical cancer. Insights Imaging. 2010; 1: 309–328. https://doi.org/10.1007/s13244-010-0042-7.; Li Z., Li H., Wang S., Dong D., Yin F., Chen A., Wang S., Zhao G., Fang M., Tian J., Wu S., Wang H. MR-based radiomics nomogram of cervical cancer in prediction of the lymph-vascular space invasion preoperatively. J. Magn. Reson. Imaging. 2019; 49 (5): 1420–1426. https://doi.org/10.1002/jmri.26531.; Braithwaite A.C., Dale B.M., Boll D.T., Merkle E.M. Shortand midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen. Radiology. 2009; 250: 459–465. https://doi.org/10.1148/radiol.2502080849.; Rutledge F.N., Mitchell M.F., Munsell M., Bass S., McGuffee V., Atkinson E.N. Youth as a prognostic factor in carcinoma of the cervix: a matched analysis. Gynecol. Oncol. 1992; 44: 123–130.; Delaloye J.F., Pampallona S., Coucke P.A., De Grandi P. Younger age as a bad prognostic factor in patients with carcinoma of the cervix. Eur. J. Obstet. Gynecol. Reprod. Biol. 1996; 64: 201–205.; Gui B., Valentini A.L., Miccò M., D'Agostino G.R., Tagliaferri L., Zannoni G.F., Fanfani F., Manfredi R., Bonomo L. Cervical cancer response to neoadjuvant chemoradiotherapy: MRI assessment compared with surgery. Acta Radiol. 2016; 57 (9): 1123–1131. https://doi.org/10.1177/0284185115617346.; Vincens E., Balleyguier C., Rey A., Uzan C., Zareski E., Gouy S., Pautier P., Duvillard P., Haie-Meder C., Morice P. Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy: correlation of radiologic findings with surgicopathologic results. Cancer. 2008; 113 (8): 2158–2165. https://doi.org/10.1002/cncr.23817.; Hameeduddin A., Sahdev A. Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies Cancer Imaging. 2015; 15 (1): 3. https://doi.org/10.1186/s40644-015-0037-1.; Kuang F., Ren J., Zhong Q., Liyuan F., Huan Y., Chen Z. The value of apparent diffusion coefficient in the assessment of cervical cancer. Eur. Radiol. 2013; 23: 1050–1058. https://doi.org/10.1007/s00330-012-2681-1.; Lucas R., Dias J.L., Cunha T.M. Added value of diffusionweighted MRI in detection of cervical cancer recurrence: comparison with morphologic and dynamic contrastenhanced MRI sequences Diagn. Interv. Radiol. 2015; 21 (5): 368–375. https://doi.org/10.5152/dir.2015.14427.; Mayr N.A., Yuh W.T.C., Jajoura D., Wang J.Z., Lo S.S., Montebello J.F., Porter K., Zhang D., McMeekin D.S., Buatti J.M. Ultra-early Predictive Assay for Treatment Failure Using Functional Magnetic Resonance Imaging and Clinical Prognostic Parameters in Cervical Cancer. Cancer. 2010; 116 (4): 903–912. https://doi.org/10.1002/cncr.24822.; https://medvis.vidar.ru/jour/article/view/797
-
5Academic Journal
Authors: P. Yu. Grishko, S. S. Balyasnikova, D. V. Samsonov, A. V. Mishchenko, A. M. Karachun, I. V. Pravosudov, П. Ю. Гришко, С. С. Балясникова, Д. В. Самсонов, А. В. Мищенко, А. М. Карачун, И. В. Правосудов
Source: Medical Visualization; № 2 (2019); 7-26 ; Медицинская визуализация; № 2 (2019); 7-26 ; 2408-9516 ; 1607-0763
Subject Terms: магнитно-резонансная томография, diagnostics, disease extent assessment, neoadjuvant chemotherapy, magnetic resonance imaging, диагностика, оценка распространенности, неоадъювантное лечение
File Description: application/pdf
Relation: https://medvis.vidar.ru/jour/article/view/766/543; Glynne-Jones R., Wyrwicz L., Tiret E., Brown G., Rodel C., Cervantes A., Arnold D., ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2017; 28 (Suppl. 4): 22–40. http://doi.org/10.1093/annonc/mdx224.; American Cancer Society. Cancer Facts & Figures. 2017. Available at: https://www.cancer.org/content/dam/ cancer-org/research/cancer-facts-and-statistics/ annual-cancer-facts-and-figures/2017/cancer-factsand-figures-2017.pdf (accessed August 12, 2018).; Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2009 г. Вестник РОНЦ им. Н.Н. Блохина РАМН. 2011; 22 (3, Прил. 1) (85): 1–170.; Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2017 году. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ “НМИЦ радиологии” Минздрава России, 2018. 250 с.; Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2016 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена – филиал ФГБУ “НМИЦ радиологии” Минздрава России, 2018. 250 с.; Morson B. President's address. The polyp-cancer sequence in the large bowel. Proc. Royal Soc. Med. 1974; 67 (6): 451–457.; Kang H., O'Connell J.B., Leonardi M.J., Maggard M.A., McGory M.L., Ko C.Y. Rare tumors of the colon and rectum: a national review. Int. J. Colorectal Dis. 2007; 22 (2): 183–189.; Union for International Cancer Control (UICC). Available at: https://www.hoofdhalskanker.info/wpavl/wp-content/ uploads/TNM-Classification-of-Malignant-Tumours-8thedition.pdf. (accessed August 12, 2018).; Balyasnikova S., Brown G. Imaging Advances in Colorectal Cancer. Curr. Colorectal Cancer Rep. 2016; 12 (3): 162–169. http://doi.org/10.1007/s11888-016-0321-x.; Beets-Tan R.G.H., Lambregts D.M.J., Maas M., Bipat S., Barbaro B., Curvo-Semedo L., Fenlon H.M., Gollub M.J., Gourtsoyianni S., Halligan S., Hoeffel C., Kim S.H., Laghi A., Maier A., Rafaelsen S.R., Stoker J., Taylor S.A., Torkzad M.R., Blomqvist L. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastro intestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur. Radiol. 2018; 28 (4): 1465–1475. http://doi.org/10.1007/s00330-017-5026-2.; Peschaud F., Benoist S., Julie C., Penna C., Nordlinger B. The mesorectum: an anatomical entity that is difficult to evaluate with MRI. Morphologie: bulletin de l'Association des anatomistes. 2005; 89 (286): 126–130.; Rodel C., Sauer R., Fietkau R. The Role of Magnetic Resonance Imaging to Select Patients for Preoperative Treatment in Rectal Cancer. Strahlentherapie Onkol. 2009; 185 (8): 488–492. http://doi.org/10.1007/s00066-009-2043-3.; Al-Sukhni E., Milot L., Fruitman M., Beyene J., Victor J.C., Schmocker S., Brown G., McLeod R., Kennedy E. Diagnostic Accuracy of MRI for Assessment of T Category, Lymph Node Metastases, and Circumferential Resection Margin Involvement in Patients with Rectal Cancer: A Systematic Review and Meta-analysis. Ann. Surg. Oncol. 2012; 19 (7): 2212–2223. http://doi.org/10.1245/s10434-011-2210-5.; Karatag O., Karatag G.Y., Ozkurt H., Degirmenci H.K., Avlanmis O., Basak M., Baykan A. The ability of phasedarray MRI in preoperative staging of primary rectal cancer: correlation with histopathological results. Diagn. Interv. Radiol. 2012; 18 (1): 20–26. http://doi.org/10.4261/1305-3825.DIR.3394-10.2.; Kim S.H., Lee J.M., Park H.S., Eun H.W., Han J.K., Choi B.I. Accuracy of MRI for Predicting the Circumferential Resection Margin, Mesorectal Fascia Invasion, and Tumor Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. J. Magn. Reson. Imaging. 2009; 29 (5): 1093–1101. http://doi.org/10.1002/jmri.21742.; Koh D.M., Brown G., Temple L., Blake H., Raja A., Toomey P., Bett N., Farhat S., Norman A.R., Daniels I., Husband J.E. Distribution of mesorectal lymph nodes in rectal cancer: in vivo MR imaging compared with histopathological examination. Initial observations. Eur. Radiol. 2005; 15 (8): 1650–1657. http://doi.org/10.1007/s00330-005-2751-8.; Nougaret S., Reinhold C., Mikhael H.W., Rouanet P., Bibeau F., Brown G. The Use of MR Imaging in Treatment Planning for Patients with Rectal Carcinoma: Have You Checked the “DISTANCE”? Radiology. 2013; 268 (2): 329–343. http://doi.org/10.1148/radiol.13121361.; Patel U.B., Taylor F., Blomqvist L., George C., Evans H., Tekkis P., Quirke P., Sebag-Montefiore D., Moran B., Heald R., Guthrie A., Bees N., Swift I., Pennert K., Brown G. Magnetic Resonance Imaging-Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY Experience. J. Clin. Oncol. 2011; 29 (28): 3753–3760. http://doi.org/10.1200/JCO.2011.34.9068.; Piippo U., Paakko E., Makinen M., Makela J. Local staging of rectal cancer using the black lumen magnetic resonance imaging technique. Scand. J. Surg. 2008; 97 (3): 237–242. http://doi.org/10.1177/145749690809700306.; Mulla M., Deb R., Singh R. MRI in T staging of rectal cancer: How effective is it? Indian J. Radiol. Imaging. 2010; 20 (2): 118–121. http://doi.org/10.4103/0971-3026.63055.; Vliegen R.F.A., Beets G.L., von Meyenfeldt M.F., Kessels A.G.H., Lemaire E., van Engelshoven J.M.A., Beets-Tan R.G.H. Rectal cancer: MR Imaging in local staging – Is gadolinium-based contrast material helpful? Radiology. 2005; 234 (1): 179–188. http://doi.org/10.1148/radiol.2341031403.; Jao S.Y., Yang B.Y., Weng H.H., Yeh C.H., Lee L.W. Evaluation of gadolinium-enhanced T1-weighted magnetic resonance imaging in the preoperative assessment of local staging in rectal cancer. Colorectal Dis. 2010; 12 (11): 1139–1148. http://doi.org/10.1111/j.1463-1318.2009.01959.x.; Lambregts D.M.J., Vandecaveye V., Barbaro B., Bakers F.C.H., Lambrecht M., Maas M., Hauster mans K., Valentini V., Beets G.L., Beets-Tan R.G.H. Diffusionweighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann. Surg. Oncol. 2011; 18 (8): 2224–2231. http://doi.org/10.1245/s10434-011-1607-5.; Foti P.V., Privitera G., Piana S., Palmucci S., Spatola C., Bevilacqua R., Raffaele L., Salamone V., Caltabiano R., Magro G., Destri G.L., Milone P., Ettorre G.C. Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemoradiotherapy. Eur. J. Radiol. Open. 2016; 3: 145–152. http://doi.org/10.1016/j.ejro.2016.06.003.; Brown G. Thin section MRI in multidisciplinary preoperative decision making for patients with rectal cancer. Br. J. Radiol. 2005; 78: 117–127. http://doi.org/10.1259/bjr/15128198.; Dukes C.E. The classification of cancer of the rectum. The Journal of Pathology and Bacteriology. 1932; 35 (3): 323–332.; Brown G. Staging rectal cancer: endoscopic ultrasound and pelvic MRI. Cancer Imaging. 2008; 8 (A): 43–45. http://doi.org/10.1102/1470-7330.2008.9008.; Kikuchi R., Takano M., Takagi K., Fujimoto N., Nozaki R., Fujiyoshi T., Uchida Y. Management of early invasive colorectal-cancer – risk of recurrence and clinical guidelines. Dis. Colon. Rectum. 1995; 38 (12): 1286–1295.; Puli S.R., Bechtold M.L., Reddy J.B.K., Choudhary A., Antillon M.R. Can Endoscopic Ultrasound Predict Early Rectal Cancers That Can Be Resected Endoscopically? A Meta-Analysis and Systematic Review. Dig. Dis. Sci. 2010; 55 (5): 1221–1229. http://doi.org/10.1007/s10620-009-0862-9.; Balyasnikova S., Read J., Wotherspoon A., Rasheed S., Tekkis P., Tait D., Cunningham D., Brown G. Diagnostic accuracy of high-resolution MRI as a method to predict potentially safe endoscopic and surgical planes in patients with early rectal cancer. BMJ Open Gastroenterol. 2017; 4 (1): e000151. http://doi.org/10.1136/bmjgast-2017-000151.; Brown G., Daniels I.R., Heald R.J., Quirke P., Blomqvist L., Sebag-Montefiore D., Moran B.J., Holm T., Strassbourg J., Peppercorn P.D., Fisher S.E., Mason B., Grp M.S. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. Br. Med. J. 2006; 333 (7572): 779–782. http://doi.org/10.1136/bmj.38937.646400.55.; Kaur H., Choi H., You Y.N., Rauch G.M., Jensen C.T., Hou P., Chang G.J., Skibber J.M., Ernst R.D. MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics. 2012; 32 (2): 389–409. http://doi.org/10.1148/rg.322115122; Taylor F.G.M., Quirke P., Heald R.J., Moran B., Blomqvist L., Swift I., Sebag-Montefiore D.J., Tekkis P., Brown G., Grp M.S. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone a prospective, multicenter, european study. Ann. Surg. 2011; 253 (4): 711–719. http://doi.org/10.1097/SLA.0b013e31820b8d52.; Benson A.B. 3rd, Venook A.P., Al-Hawary M.M., Cederquist L., Chen Y.-J., Ciombor K.K., Cohen S., Cooper H.S., Deming D., Engstrom P.F., Grem J.L., Grothey A., Hochster H.S., Hoffe S., Hunt S., Kamel A., Kirilcuk N., Krishnamurthi S., Messersmith W.A., Meyerhardt J., Mulcahy M.F., Murphy J.D., Nurkin S., Saltz L., Sharma S., Shibata D., Skibber J.M., Sofocleous C.T., Stoffel E.M., Stotsky-Himelfarb E., Willett C.G., Wuthrick E., Gregory K.M., Gurski L., Freedman-Cass D.A. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. (JNCCN). 2018; 16 (7): 874–901. http://doi.org/10.6004/jnccn.2018.0061.; Al-Sukhni E., Milot L., Fruitman M., Brown G., Schmocker S., Kennedy E. User’s Guide for the Synoptic MRI Report for Rectal Cancer. Cancer Care Ontario. Canadian Cancer Society. Available at: http://www.osumcradiology. org/resources/High-Yield-Rad-info/Rectal-MRI.pdf (accessed August 12, 2018). (In Russian).; Moran M.R., James E.C., Rothenberger D.A., Goldberg S.M. Prognostic value of positive lymph-nodes in rectal-cancer. Dis. Colon. Rectum. 1992; 35 (6): 579–581.; Quirke P., Williams G. Minimum dataset for colorectal cancer histopathology reports. London: Royal College of Pathologists, 2000.; Bipat S., Glas A.S., Slors F.J.M., Zwinderman A.H., Bossuyt P.M.M., Stoker J. Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging – A meta-analysis. Radiology. 2004; 232 (3): 773–783. http://doi.org/10.1148/radiol.2323031368.; Schnall M.D., Furth P.E.E., Rosato E.F., Kressel H.Y. Rectal tumor stage – correlation of endorectal MR-imaging and pathological findings. Radiology. 1994; 190 (3): 709–714. http://doi.org/10.1148/radiology.190.3.8115616.; Brown G., Richards C.J., Bourne M.W., Newcombe R.G., Radcliffe A.G., Dallimore N.S., Williams G.T. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histo pathologic comparison. Radiology. 2003; 227 (2): 371–377. http://doi.org/10.1148/radiol.2272011747.; Kotanagi H., Fukuoka T., Shibata Y., Yoshioka T., Aizawa O., Saito Y., Tur G.E., Koyama K. The size of regional lymphnodes does not correlate with the presence or absence of metastasis in lymph-nodes in rectal-cancer. J. Surg. Oncol. 1993; 54 (4): 252–254.; Markl B., Rossle J., Arnholdt H.M., Schaller T., Krammer I., Cacchi C., Jahnig H., Schenkirsch G., Spatz H., Anthuber M. The clinical significance of lymph node size in colon cancer. Mod. Pathol. 2012; 25 (10): 1413–1422. http://doi.org/10.1038/modpathol.2012.92.; Smith N.J., Shihab O., Arnaout A., Swift R.I., Brown G. MRI for detection of extramural vascular invasion in rectal cancer. Am. J. Roentgenol. 2008; 191 (5): 1517–1522. http://doi.org/10.2214/AJR.08.1298.; Chand M., Swift R.I., Tekkis P.P., Chau I., Brown G. Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br. J. Cancer. 2014; 110 (1): 19–25. http://doi.org/10.1038/bjc.2013.603.; Chand M., Evans J., Swift R.I., Tekkis P.P., West N.P., Stamp G., Heald R.J., Brown G. The prognostic significance of postchemoradiotherapy high-resolution MRI and histopathology detected extramural venous invasion in rectal cancer. Ann. Surg. 2015; 261 (3): 473–479. http://doi.org/10.1097/SLA.0000000000000848.; Faes S., Gie O., Demartines N., Hahnloser D. Multidisciplinary treatment of locally advanced rectal cancer. Rev. Med. Suisse. 2016; 12 (523): 1185–1189. (In French); Miles W.E. A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. The Lancet. 1908; 172 (4451): 1812–1813.; Heald R.J. The holy plane of rectal surgery. J. R. Soc. Med. 1988; 81 (9): 503–508. PMID: 3184105.; Heald R.J., Moran B.J., Ryall R.D.H., Sexton R., MacFarlane J.K. Rectal cancer – the basingstoke experience of total mesorectal excision, 1978–1997. Arch. Surg. 1998; 133 (8): 894–898.; Quirke P., Dixon M.F., Durdey P., Williams N.S. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection – histopathological study of lateral tumor spread and surgical excision. Lancet. 1986; 2 (8514): 996–999.; Taylor F.G.M., Quirke P., Heald R.J., Moran B.J., Blomqvist L., Swift I.R., Sebag-Montefiore D., Tekkis P., Brown G. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year followup results of the MERCURY study. J. Clin. Oncol. 2014; 32 (1): 34–114. http://doi.org/10.1200/JCO.2012.45.3258.; Bown E.J., Lloyd G.M., Boyle KM., Miller A.S. Rectal cancer: prognostic indicators of long-term outcome in patients considered for surgery. Int. J. Colorectal. Dis. 2014; 29 (2): 147–155. http://doi.org/10.1007/s00384-013-1772-z.; Zhao J., Du C.Z., Sun Y.S., Gu J. Patterns and prognosis of locally recurrent rectal cancer following multi disciplinary treatment. Wld J. Gastroenterol. 2012; 18 (47): 7015–7020. http://doi.org/10.3748/wjg.v18.i47.7015.; Purkayastha S., Tekkis P.P., Athanasiou T., Tilney H.S., Darzi A.W., Heriot A.G. Diagnostic precision of magnetic resonance imaging for preoperative prediction of the circumferential margin involvement in patients with rectal cancer. Colorectal Dis. 2007; 9 (5): 402–411. http://doi.org/10.1111/j.1463-1318.2006.01104.x.; Taylor F.G.M., Quirke P., Heald R.J., Moran B., Blomqvist L., Swift I., St Rose S., Sebag-Montefiore D.J., Tekkis P., Brown G., Grp M.S. One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer. Br. J. Surg. 2011; 98 (6): 872–879. DOI:10.1002/bjs.7458.; Rullier E., Denost Q., Vendrely V., Rullier A., Laurent C. Low rectal cancer: classification and standardization of surgery. Dis. Colon. Rectum. 2013; 56 (5): 560–567. http://doi.org/10.1097/DCR.0b013e31827c4a8c.; Perez R., Habr-Gama A., Camargo A., Souza S., Parmigiani R., Galante P., Salim A., Souza J., Quevedo B., Felicio N., Gama-Rodrigues J. Prediction of response to neoadjuvant chemoradiation therapy in patients with distal rectal cancer by gene expression using last generation sequencing. Dis. Colon. Rectum. 2011; 54 (5): Е7–E7.; Черниковский И.Л. Мультидисциплинарный подход в диагностике и лечении резектабельного рака прямой кишки. Практическая онкология. 2015; 16 (2): 69–76.; Sauer R., Becker H., Hohenberger W., Rodel C., Wittekind C., Fietkau R., Martus P., Tschmelitsch J., Hager E., Hess C.F., Karstens J.H., Liersch T., Schmidberger H., Raab R., German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. New Engl. J. Med. 2004; 351 (17): 1731–1740. http://doi.org/10.1056/NEJMoa040694.; Hotker A.M., Tarlinton L., Mazaheri Y., Woo K.M., Gonen M., Saltz L.B., Goodman K.A., Garcia-Aguilar J., Gollub M.J. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemo radiotherapy: A comparison of morphological, volumetric and functional MRI parameters. Eur. Radiol. 2016; 26 (12): 4303–4312. http://doi.org/10.1007/s00330-016-4283-9.; Dworak O., Keilholz L., Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int. J. Colorectal Dis. 1997; 12 (1): 19–23.; Camma C., Giunta M., Fiorica F., Pagliaro L., Craxi A., Cottone M. Preoperative radiotherapy for resectable rectal cancer – a meta-analysis. J. Am. Med. Ass. 2000; 284 (8): 1008–1015.; Bhangu A., Ali S.M., Cunningham D., Brown G., Tekkis P. Comparison of long-term survival outcome of operative vs nonoperative management of recurrent rectal cancer. Colorectal Dis. 2013; 15 (2): 156–163. http://doi.org/10.1111/j.1463-1318.2012.03123.x.; Тюряева Е.И. Химиолучевое лечение рака прямой кишки. Практическая онкология. 2008; 9 (1): 31–38.; Keam S.J., Dunn C.J., Figgitt D.P. Oxaliplatin – in operable colorectal cancer. Drugs. 2005; 65 (1): 89–96. http://doi.org/10.2165/00003495-200565010-00005.; Hoetker A.M., Garcia-Aguilar J., Gollub M.J. Multiparametric MRI of rectal cancer in the assessment of response to therapy: a systematic review. Dis. Colon Rectum. 2014; 57 (6): 790–799. http://doi.org/10.1097/DCR.0000000000000127.; Evans J., Tait D., Swift I., Pennert K., Tekkis P., Wotherspoon A., Chau I., Cunningham D., Brown G. Timing of surgery following preoperative therapy in rectal cancer: the need for a prospective randomized trial? Dis. Colon Rectum. 2011; 54 (10): 1251–1259. http://doi.org/10.1097/DCR.0b013e3182281f4b.; Patel U.B., Brown G., Rutten H., West N., SebagMontefiore D., Glynne-Jones R., Rullier E., Peeters M., Van Cutsem E., Ricci S., Van de Velde C., Kjell P., Quirke P. Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Ann. Surg. Oncol. 2012; 19 (9): 2842–2852. http://doi.org/10.1245/s10434-012-2309-3.; Patel U.B., Brown G. MRI-based assessment of tumor regression in rectal cancer. Curr. Colorectal Cancer Rep. 2013; 9 (2): 136–145. http://doi.org/10.1007/s11888-013-0169-2.; Sassen S., de Booij M., Sosef M., Berendsen R., Lammering G., Clarijs R., Bakker M., Beets-Tan R., Warmerdam F., Vliegen R. Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy? Eur. Radiol. 2013; 23 (12): 3440–3449. http://doi.org/10.1007/s00330-013-2956-1.; Park M.J., Kim S.H., Lee S.J., Jang K.M., Rhim H. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy. Radiology. 2011; 260 (3): 771–780. http://doi.org/10.1148/radiol.11102135.; Boone D., Taylor S.A., Halligan S. Diffusion weighted MRI: overview and implications for rectal cancer management. Colorectal Dis. 2013; 15 (6): 655–661. http://doi.org/10.1111/codi.12241.; Heijnen L.A., Lambregts D.M.J., Mondal D., Martens M.H., Riedl R.G., Beets G.L., Beets-Tan R.G.H. Diffusionweighted MR imaging in primary rectal cancer staging demonstrates but does not characterise lymph nodes. Eur. Radiol. 2013; 23 (12): 3354–3360. http://doi.org/10.1007/s00330-013-2952-5.; Alberda W.J., Dassen H.P.N., Dwarkasing R.S., Willemssen F.E.J.A., van der Pool A.E.M., de Wilt J.H.W., Burger J.W. A., Verhoef C. Prediction of tumor stage and lymph node involvement with dynamic contrastenhanced MRI after chemoradiotherapy for locally advanced rectal cancer. Int. J. Colorectal Dis. 2013; 28 (4): 573–580. http://doi.org/10.1007/s00384-012-1576-6.; Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J. Clin. Oncol. 2006; 24 (20): 3293–3298. http://doi.org/10.1200/JCO.2006.06.8080.; Fusco R., Sansone M., Petrillo M., Avallone A., Delrio P., Petrillo A. Dynamic Contrast Enhanced Magnetic Resonance Imaging in Rectal Cancer. Rectal Cancer-A Multidisciplinary Approach to Management / Giulio D., Santoro A. InTech. 2011; 75–98.; Arya S., Das D., Engineer R., Saklani A. Imaging in rectal cancer with emphasis on local staging with MRI. Indian J. Radiol. Imaging. 2015; 25 (2): 148–161. http://doi.org/10.4103/0971-3026.155865.; https://medvis.vidar.ru/jour/article/view/766
-
6Academic Journal
Authors: I. A. Kosenko, T. M. Litvinova, O. P. Matylevich, И. А. Косенко, Т. М. Литвинова, О. П. Матылевич
Source: Siberian journal of oncology; Том 15, № 1 (2016); 44-48 ; Сибирский онкологический журнал; Том 15, № 1 (2016); 44-48 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2016-15-1
Subject Terms: выживаемость, surgical treatment, chemotherapy, embolization, neoadjuvant treatment, survival, хирургическое лечение, химиотерапия, эмболизация, неоадъювантное лечение
File Description: application/pdf
Relation: https://www.siboncoj.ru/jour/article/view/307/309; Вашкевич Л.Б. и др. Рентгеноэндоваскулярные вмешательства при неоадъюватном лечении больных с местно-распространенными саркомами мягких тканей и костей // Актуальные проблемы онкологии и мед. радиологии. Минск, 2000. С. 245–253.; Исаев И.Г., Гулиев Э.Г., Акперов К.С. Лучевая терапия рака шейки матки при наличии метастазов в регионарных лимфоузлах // Евразийский онкологический журнал. Тезисы VII съезда онкологов и радиологов СНГ и Евразии. Казань, 2014. № 3. С. 552–553.; Косенко И.А. Рак шейки матки с неблагоприятным прогнозом. Гомель: Гомельский государственный медицинский университет, 2007. 192 с.; Косенко И.А. Оптимизация лучевого и комплексного лечения больных раком шейки майки с неблагоприятным прогнозом: Автореф. дис. …д-ра мед. наук. Минск, 2000. 44 с.; Кравец О.А., Базаева И.Я., Хохлова С.В. Современная стратегия лечения местно-распространенного рака шейки матки // Евразийский онкологический журнал. Тезисы VII съезда онкологов и радиологов СНГ и Евразии. Казань, 2014. № 3. С. 560–561.; Переводчикова Н.И. Изменение арсенала противоопухолевых препаратов за последние 15 лет и современные возможности химиотерапии опухолевых заболеваний // Материалы IX Российского онкологического конгресса. М., 2005. С. 64–68.; Сабекия И.М., Столярова И.В., Винокуров В.Л. Роль рентгено-эндоваскулярных вмешательств в комбинированном лечении больных местно-распространенным раком шейки матки // Вопросы онкологии. 2004. Т. 50, № 5. С. 590–594.; Столярова И.В. Интервенционные радиологические вмешательства у больных раком матки // Материалы научно-практической конференции «Роль лучевой терапии в гинекологической онкологии». Обнинск, 2002. С. 187–188.; Тихомиров А.Л., Лубнин Д.М. Миома матки. М., 2006. 176 с.; Халафян А.А. Statistica 6. Статистический анализ данных. М., 2008. 512 с.; Beneditti-Paniti P., Bellati F., Manci N., Pernice M., Plotti F., Di Donato V., Calcagno M., Zullo M.A., Muzii L., Angioli R. Neoadjuvant chemotherapy followed by radical surgery in patients affected stage IVA cervical cancer // Ann. Surg. Oncol. 2007. Vol. 14 (9). P. 2643–2648.; Beneditti-Paniti P., Bellati F., Pastore M., Manci N., Musella A., Pauselli S., Angelucci M., Muzii L., Angioli R. An update in neoadjuvant chemotherapy in cervical cancer // Gynecol Oncol. 2007. Vol. 107 (1). P. 20–22.; Karpenko A.A., Borisova O.G., Gur’eva V.A., Molchanova I.V. Endovascular surgery in the treatment of patients with myoma uteri // Angiol. Sosud. Khir. 2004. Vol. 10 (2). P. 36–39.; https://www.siboncoj.ru/jour/article/view/307
-
7Academic Journal
Authors: V. A. Aliyev, Yu. A. Barsukov, A. V. Nikolayev, R. I. Tamrazov, Z. Z. Mamedli, A. O. Atroshchenko, D. V. Kuzmichev, В. А. Алиев, Ю. А. Барсуков, А.В. В. Николаев, Р. И. Тамразов, З. З. Мамедли, А. О. Атрощенко, Д. В. Кузьмичев
Source: Surgery and Oncology; № 4 (2012); 15-20 ; Хирургия и онкология; № 4 (2012); 15-20 ; 2949-5857 ; 10.17650/2220-3478-2012-0-4
Subject Terms: RO-резекции, rectal cancer, cytoreductive surgery, chemotherapy, neoadjuvant treatment, R0 resection, рак прямой кишки, циторедуктивные операции, полихимиотерапия, неоадъювантное лечение
File Description: application/pdf
Relation: https://www.onco-surgery.info/jour/article/view/60/55; Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2009 г. Вестник РОНЦ им. Н.Н. Блохина РАМН 2011;22:3(85) (прил. 1).; Барсуков Ю.А., Алиев В.А., Черкес В.Л. и др. Циторедуктивные операции при метастатическом колоректальном раке. Вестник РОНЦ им. Н.Н. Блохина РАМН ;3:15–7.; Wittekind C., Compton C., Quirke P. et al. A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status. Cancer 2009;115(15):3483–8. doi:10.1002/cncr.24320; Кныш В.И. Рак прямой и ободочной кишки. М.: Медицина, 1997. С. 5, 259–263.; Переводчикова Н.И. Химиотерапия диссеминированного колоректального рака. Человек и здоровье. М., 2000.; Патютко Ю.И., Чучуев Е.С., Подлужный Д.В. и др. Хирургическая тактика в лечении больных колоректальным раком с синхронными метастазами в печень. Онкологическая колопроктология 2011;2:13–19.; Tebbutt N.C., Norman A.R., Cunningham D. et al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Ann Surg Oncol 2003;52(4):568–73; Muratore A., Zorzi D., Bouzari H. et al. Asymptomatic colorectal cancer with un-resectable liver metastases: immediate colorectal resection or up-front systemic chemotherapy? Ann Surg Oncol 2007;14(2):766–70.; Scheer M.G.W., Sloots C.E.J., van der Wilt G.J. et al. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann of Oncol 2008. Advance Access published July 28.; Scoggins C.R., Meszoely I.M., Blanke C.D. et al. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 1999;6(7):651–7.; Naredi P. Databases of hepatic resection for metastatic colorectal cancer--useful aids; for clinical decision-making. Surg Oncol 2008 Jul;17(1):15–6. Epub 2008 Jan 9.; Nash G.M., Saltz L.B., Kemeny N.E. et al. Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Ann Surg Oncol 2002 Dec;9(10):954–60.; Ruo L., DeMatteo R.P., Blumgart L.H. The role of adjuvant therapy after liver resection for colorectal cancer metastases. Clin Colorectal Cancer 2001 Nov;1(3):154–66; discussion 167–8.; Galizia G., Lieto E., Orditura M. et al. First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. Arch Surg 2008 Apr;143(4):352–8; discussion 358.; Tveit K.M., Guren T., Glimelius B. et al. Phase III trial of cetuximab with continuous; or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study. J Clin Oncol 2012 May 20; 30(15):1755–62. Epub 2012 Apr 2.; Maughan T.S., Adams R.A., Smith C.G. et al. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet 2011 Jun 18;377(9783):2103–14. Epub 2011 Jun 5.; Савина И.А, Моисеенко В.М., Васильев С.В., Симонов Н.Н. Показатели выживаемости больных раком ободочной кишки с отдаленными метастазами после; операций различного объема. Вопросы онкологии 2003;49(3):340–5.; van Dijk T.H. et al. Short-course radiation therapy, neoadjuvant bevacizumab, capecitabine and oxaliplatin, and radical resection of primary tumour and metastases in primary stage IV rectal cancer. Ann of Oncol 2010;21(suppl 1) post 98, p. 51.; Suarez J. et al. Chemotherapy vs chemoradiotherapy as neoadjuvant treatment for metastatic rectal cancer: a study of local control. Ann of Oncol 2010;21(suppl 1) post 85, p. 46.; Бохман Я.В, Лившиц М.А., Винокуров В.Л. Новые подходы к лечению гинекологического рака. СПб.: Гиппократ, 1993. С. 18.; Adam R. The importance of visceral metastasectomy in colorectal cancer. Ann; Oncol 2000;11:29–36.; Poston G. Overview of colorectal cancer with synchronous liver metastases: what; order of treatment. 14th Congress of the ESSO Hague, Netherlands. Eur J Surg Oncol 2008;9(poster 175):1040.; Секачева М.И., Полищук Л.О., Багмет Н.Н., Скипенко О.Г. Результаты хирургического лечения метастатического колоректального рака после проведения; лекарственной терапии с добавлением бевацизумаба. Современная онкология ;2(14):38.; Вашакмадзе Л.А., Сидоров Д.В., Трахтенберг А.Х. и др. Циторедуктивные; операции в лечении метастатического колоректального рака. Материалы; VI Всероссийского съезда онкологов. Ростов-на-Дону, 2005. С. 279–280.; Симонов Н.Н. Хирургическое лечение рака прямой кишки при наличии; отдаленных метастазов. Практическая онкология 2002;2(3):130–3.; Барсуков Ю.А., Ткачев С.И., Николаев А.В. и др. Комбинированное; и комплексное лечение рака прямой кишки. Методические рекомендации.; М.: Изд. группа РОНЦ, 2011.; Бердов Б.А., Почуев Т.П. Роль лучевой терапии в лечении первичной опухоли у больных колоректальным раком с синхронными метастазами в печень.; Материалы V съезда онкологов и радиологов СНГ, Ташкент, 2008. С. 503.
-
8Academic Journal
Authors: Алиев, В., Барсуков, Ю., Николаев, А., Тамразов, Р., Мамедли, З., Атрощенко, А., Кузьмичев, Д.
Subject Terms: МЕТАСТАТИЧЕСКИЙ КОЛОРЕКТАЛЬНЫЙ РАК, РАК ПРЯМОЙ КИШКИ, ЦИТОРЕДУКТИВНЫЕ ОПЕРАЦИИ, ПОЛИХИМИОТЕРАПИЯ, НЕОАДЪЮВАНТНОЕ ЛЕЧЕНИЕ, RO-РЕЗЕКЦИИ
File Description: text/html
-
9Academic Journal
Authors: Луд, Н., Угляница, К., Луд, Л.
Subject Terms: РАК МОЛОЧНОЙ ЖЕЛЕЗЫ, ПРЕДОПЕРАЦИОННАЯ ХИМИОТЕРАПИЯ И ЭНДОКРИННАЯ ТЕРАПИЯ, НЕОАДЪЮВАНТНОЕ ЛЕЧЕНИЕ, ИНГИБИТОРЫ АРОМАТАЗЫ, ТАМОКСИФЕН
File Description: text/html
-
10Academic Journal
Authors: Гладков, О., Важенин, А., Лукин, А., Шарабура, Т., Лукина, Е., Кретов, П.
Subject Terms: РАК ПИЩЕВОДА, КОМБИНИРОВАННОЕ НЕОАДЪЮВАНТНОЕ ЛЕЧЕНИЕ
File Description: text/html
-
11Academic Journal
Authors: Мачак, Г.
Subject Terms: ЛОКАЛИЗОВАННАЯ ОСТЕОСАРКОМА, ХИМИОТЕРАПИЯ, НЕОАДЪЮВАНТНОЕ ЛЕЧЕНИЕ, ЛОКАЛЬНЫЙ КОНТРОЛЬ
File Description: text/html
-
12Academic Journal
Source: Онкологическая колопроктология.
Subject Terms: МЕТАСТАТИЧЕСКИЙ КОЛОРЕКТАЛЬНЫЙ РАК, РАК ПРЯМОЙ КИШКИ, ЦИТОРЕДУКТИВНЫЕ ОПЕРАЦИИ, ПОЛИХИМИОТЕРАПИЯ, НЕОАДЪЮВАНТНОЕ ЛЕЧЕНИЕ, RO-РЕЗЕКЦИИ, 3. Good health
File Description: text/html
-
13Academic Journal
Source: Сибирский онкологический журнал.
Subject Terms: 03 medical and health sciences, 0302 clinical medicine, РАК ПИЩЕВОДА, КОМБИНИРОВАННОЕ НЕОАДЪЮВАНТНОЕ ЛЕЧЕНИЕ, 3. Good health
File Description: text/html
-
14Academic Journal
Source: Новости хирургии.
Subject Terms: РАК МОЛОЧНОЙ ЖЕЛЕЗЫ, ПРЕДОПЕРАЦИОННАЯ ХИМИОТЕРАПИЯ И ЭНДОКРИННАЯ ТЕРАПИЯ, НЕОАДЪЮВАНТНОЕ ЛЕЧЕНИЕ, ИНГИБИТОРЫ АРОМАТАЗЫ, ТАМОКСИФЕН
File Description: text/html
-
15Academic Journal
Source: Вестник РОНЦ им. Н. Н. Блохина РАМН.
Subject Terms: 3. Good health, ЛОКАЛИЗОВАННАЯ ОСТЕОСАРКОМА, ХИМИОТЕРАПИЯ, НЕОАДЪЮВАНТНОЕ ЛЕЧЕНИЕ, ЛОКАЛЬНЫЙ КОНТРОЛЬ
File Description: text/html
-
16Academic Journal
Authors: Смоленов Е.И., Миронова Д.Ю., Колобаев И.В., Рябов А.Б., Иванов С.А., Каприн А.Д.
Source: Южно-российский онкологический журнал
Subject Terms: squamous cell carcinoma, esophageal cancer, combined treatment, neoadjuvant treatment, chemotherapy, immunotherapy, chemoradiotherapy, esophagectomy, плоскоклеточный рак, рак пищевода, комбинированное лечение, неоадъювантное лечение, химиотерапия, иммунотерапия, химиолучевая терапия, эзофагэктомия
Availability: https://repository.rudn.ru/records/article/record/105945/
